KCNN3
Small conductance calcium-activated potassium channel protein 3
Also known as: hSK3, KCa2.3, KCNN3_HUMAN, SKCA3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UGI6
- Gene
- KCNN3
- Ensembl
- ENSG00000143603
- Chromosome
- 1
- Canonical length
- 731 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels
- Subcellular location
- Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Action potentials in vertebrate neurons are followed by an afterhyperpolarization (AHP) that may persist for several seconds and may have profound consequences for the firing pattern of the neuron. Each component of the AHP is kinetically distinct and is mediated by different calcium-activated potassium channels. This gene belongs to the KCNN family of potassium channels. It encodes an integral membrane protein that forms a voltage-independent calcium-activated channel, which is thought to regulate neuronal excitability by contributing to the slow component of synaptic AHP. This gene contains two CAG repeat regions in the coding sequence. It was thought that expansion of one or both of these repeats could lead to an increased susceptibility to schizophrenia or bipolar disorder, but studies indicate that this is probably not the case. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
731 residues, UniProt reviewed canonical sequence.
>Q9UGI6|KCNN3
1 MDTSGHFHDS GVGDLDEDPK CPCPSSGDEQ QQQQQQQQQQ QPPPPAPPAA PQQPLGPSLQ
61 PQPPQLQQQQ QQQQQQQQQQ PPHPLSQLAQ LQSQPVHPGL LHSSPTAFRA PPSSNSTAIL
121 HPSSRQGSQL NLNDHLLGHS PSSTATSGPG GGSRHRQASP LVHRRDSNPF TEIAMSSCKY
181 SGGVMKPLSR LSASRRNLIE AETEGQPLQL FSPSNPPEIV ISSREDNHAH QTLLHHPNAT
241 HNHQHAGTTA SSTTFPKANK RKNQNIGYKL GHRRALFEKR KRLSDYALIF GMFGIVVMVI
301 ETELSWGLYS KDSMFSLALK CLISLSTIIL LGLIIAYHTR EVQLFVIDNG ADDWRIAMTY
361 ERILYISLEM LVCAIHPIPG EYKFFWTARL AFSYTPSRAE ADVDIILSIP MFLRLYLIAR
421 VMLLHSKLFT DASSRSIGAL NKINFNTRFV MKTLMTICPG TVLLVFSISL WIIAAWTVRV
481 CERYHDQQDV TSNFLGAMWL ISITFLSIGY GDMVPHTYCG KGVCLLTGIM GAGCTALVVA
541 VVARKLELTK AEKHVHNFMM DTQLTKRIKN AAANVLRETW LIYKHTKLLK KIDHAKVRKH
601 QRKFLQAIHQ LRSVKMEQRK LSDQANTLVD LSKMQNVMYD LITELNDRSE DLEKQIGSLE
661 SKLEHLTASF NSLPLLIADT LRQQQQQLLS AIIEARGVSV AVGTTHTPIS DSPIGVSSTS
721 FPTPYTSSSS CLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNN3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 14 nTPM
- basal ganglia: 11 nTPM
- amygdala: 9.2 nTPM
- midbrain: 8.7 nTPM
- colon: 7.3 nTPM
- skeletal muscle: 5.6 nTPM
Single-cell type
- astrocytes: 479 nCPM
- ependymal cells: 352 nCPM
- myosatellite cells: 187 nCPM
- bergmann glia: 172 nCPM
- respiratory ciliated cells: 159 nCPM
- pituitary stem cells: 158 nCPM
Immune cell
- basophil: 4.7 nTPM
- memory B-cell: 2.6 nTPM
- non-classical monocyte: 1.4 nTPM
- naive B-cell: 0.8 nTPM
- myeloid DC: 0.2 nTPM
- intermediate monocyte: 0.1 nTPM
Brain region
- midbrain: 91 nTPM
- thalamus: 75 nTPM
- amygdala: 71 nTPM
- basal ganglia: 70 nTPM
- hypothalamus: 59 nTPM
- pons: 55 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KCNN3.
Disease | AllUniProt
Conditions KCNN3 is implicated in, by any mechanism.
- Zimmermann-Laband syndrome 3 (ZLS3) MIM:618658
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 166 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Zimmermann-Laband syndrome 3
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 3.33
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- calmodulin binding
- inward rectifier potassium channel activity
- small conductance calcium-activated potassium channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCNN3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNN3 as an antibody target. Whether an autoantibody or antibody against KCNN3 could matter depends on whether native KCNN3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNN3 is annotated at the cell surface, where native KCNN3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNN3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...